All Posts
A practical approach to the guideline-directed pharmacological treatment of heart failure with reduced ejection fraction.
17 Oct, 2022 | 12:15h | UTC
RCT | Adjuvant capecitabine following concurrent CTX-RT in locoregionally advanced nasopharyngeal carcinoma.
17 Oct, 2022 | 12:15h | UTC
Cohort Study | Diagnostic yield of ECG-gated cardiac CT in the acute phase of ischemic stroke vs. transthoracic echocardiography.
17 Oct, 2022 | 12:23h | UTCDiagnostic Yield of ECG-Gated Cardiac CT in theAcute Phase of Ischemic Stroke vsTransthoracic Echocardiography – Neurology (link to abstract – $ for full-text)
Author Interview: ECG-Gated Cardiac CT in Acute Ischemic Stroke vs Transthoracic Echocardiography
Commentary: Add Cardiac CT to Acute Stroke Imaging to Detect Cardioembolism -Medscape (free registration required)
Participation of older adults in clinical trials for new drug applications and biologics license applications from 2010-2019.
17 Oct, 2022 | 12:12h | UTC
Commentary on Twitter
Underrepresentation of adults above age 75-80 years found in evaluation of new medications. 60-75 year-olds were reasonably well represented in clinical trials in proportion to the prevalence data in the US. #OAResearch https://t.co/2RL5fTo3LA
— JAMA Network Open (@JAMANetworkOpen) October 14, 2022
Cohort Study | Incidence and survival in synchronous and metachronous liver metastases from colorectal cancer.
17 Oct, 2022 | 12:14h | UTC
RCT | Effect of front-of-package information, fruit imagery, and sugar warning labels on parent beverage choices for children.
17 Oct, 2022 | 12:11h | UTC
Commentary on Twitter
Front-of-pack "HIGH ADDED SUGARS" warnings that show added sugar content in teaspoons can lead parents to choose healthier drinks for their young children, even in the presence of fruit imagery and nutrient claims. #OAReaserch https://t.co/qNzt5lFIjO
— JAMA Network Open (@JAMANetworkOpen) October 13, 2022
RCTs | Thrombectomy improved recovery in basilar artery stroke but increased procedural complications and hemorrhages.
14 Oct, 2022 | 14:20h | UTCStudy 1: Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion – New England Journal of Medicine (link to abstract – $ for full-text)
Study 2: Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion – New England Journal of Medicine (link to abstract – $ for full-text)
Related:
Commentary on Twitter
In 340 Chinese patients with basilar-artery occlusion, endovascular treatment resulted in better neurologic outcomes than medical care. Approximately one third of patients underwent intravenous thrombolysis. https://t.co/ZqHirYnjoH pic.twitter.com/fuRV3rFWX7
— NEJM (@NEJM) October 13, 2022
Review | Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease.
14 Oct, 2022 | 14:19h | UTCRelated:
Antihypertensive Deprescribing in Older Adults: a Practical Guide – Current Hypertension Reports
Deprescribing in Palliative Cancer Care – Life
Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review – Kidney360
Polypharmacy Management in Older Patients – Mayo Clinic Proceedings
Eliminating Medication Overload: A National Action Plan – Lown Institute
Common ED Medication Errors: Polypharmacy – emDocs
Current and future perspectives on the management of polypharmacy – BMC Family Practice
Polypharmacy—an Upward Trend with Unpredictable Effects – Deutsches Ärzteblatt international
Clinical Consequences of Polypharmacy in Elderly – Expert Opinion on Drug Safety
Special Statement | Postpartum visit checklists for normal pregnancy and complicated pregnancy.
14 Oct, 2022 | 14:18h | UTCOriginal Guideline: ACOG Postpartum Toolkit (PDF)
Position Statement | Chronic kidney disease as cardiovascular risk factor in routine clinical practice.
14 Oct, 2022 | 14:17h | UTC
Position Statement | Home blood pressure monitoring.
14 Oct, 2022 | 14:16h | UTCRelated:
Recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer.
14 Oct, 2022 | 14:12h | UTC
Expert Consensus | Cardiac computed tomographic imaging in cardio-oncology.
14 Oct, 2022 | 14:14h | UTC
Commentary on Twitter
New SCCT Expert Consensus co-endorsed by @ICOSociety: #YesCCT in Cardio-Oncology
This document fills existing gaps about CCT in Cardio-Oncology w experts in cardio-oncology, CCT imaging and cancer medicine @journalCCT 👉https://t.co/lNaQ37sKoQ@onco_cardiology @CardiacCTGuy pic.twitter.com/hILbBimfmZ
— Heart_SCCT (@Heart_SCCT) September 19, 2022
4-year follow-up of a RCT | Pembrolizumab with vs. without chemotherapy in recurrent or metastatic head and neck SCC.
14 Oct, 2022 | 14:11h | UTCOriginal Study: Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study – The Lancet (link to abstract – $ for full-text)
M-A | The prognostic value of CAC zero among individuals presenting with chest pain.
14 Oct, 2022 | 14:10h | UTCThe Prognostic Value of CAC Zero Among Individuals Presenting With Chest Pain: A Meta-Analysis – JACC: Cardiovascular Imaging (link to abstract – $ for full-text)
RCT | A low-intensity psychosocial intervention improved recovery from depression in older adults in Brazil.
14 Oct, 2022 | 14:09h | UTCInvited Commentary: Empowering older adults and their communities to cope with depression in resource-limited settings – The Lancet Health Longevity
Commentary on Twitter
Empowering older adults and their communities to cope with #depression in resource-limited settings https://t.co/8GShpxpcOX@clausuemoto #Geriatrics
Our commentary @LancetLongevity about the incredible PRO-ACTIVE intervention by @scazufca & cols https://t.co/x2UerUFAYY pic.twitter.com/IP0DqTmGdP
— Marlon Aliberti (@marlon_aliberti) October 3, 2022
Under a Creative Commons Attribution (CC BY 4.0) License
Cohort Study | Carotid plaque characteristics predict recurrent ischemic stroke and transient ischemic attack.
14 Oct, 2022 | 14:08h | UTC
Cohort Study | Purpose in life (Ikigai) and employment status in relation to cardiovascular mortality.
14 Oct, 2022 | 14:06h | UTC
Perspective | The case for mild stimulation for in vitro fertilization.
14 Oct, 2022 | 14:07h | UTC
Commentary on Twitter
New Review paper from @GeetaNargund & the #ISMAAR committee recommends mild ovarian stimulation for IVF should be considered in all clinical scenarios, for effective pregnancy outcomes
Safer, better tolerated and less expensive than conventional IVF.https://t.co/Jv2H2ucQUc pic.twitter.com/LtOSfE98PG
— Reproductive BioMedicine Online (@RBMOnline) September 9, 2022
Cohort Study | Elevated C-reactive protein and subsequent patient-reported cognitive problems in older breast cancer survivors.
14 Oct, 2022 | 14:03h | UTC
Review | Heart failure after right ventricular myocardial infarction.
14 Oct, 2022 | 14:05h | UTCHeart Failure After Right Ventricular Myocardial Infarction – Current Heart Failure Reports
Cluster RCT | Culturally sensitive vs. standard behavioral approach for promoting weight-loss maintenance in black women.
14 Oct, 2022 | 14:04h | UTC
Review | Point-of-care ultrasound in pediatric nephrology.
14 Oct, 2022 | 14:03h | UTCPoint-of-care ultrasound in pediatric nephrology – Pediatric Nephrology (if the link is paywalled, try this one)
M-A | Efficacy of different preoperative skin antiseptics on the incidence of surgical site infections.
14 Oct, 2022 | 14:02h | UTCRelated:
Antiseptic Skin Agents to Prevent Surgical Site Infection After Incisional Surgery: A Randomized, Three-armed Combined Non-inferiority and Superiority Clinical Trial (NEWSkin Prep Study) – Annals of Surgery (link to abstract – $ for full-text)
Commentary on Twitter
To reduce risk of surgical site infections.
👉 chlorhexidine in alcohol better than iodine (esp non-clean surgery)
👉 but only at 2-2.5%. Higher concentration not better!
👉 olanexidine possible alternative but only 1x RCT@LancetMicrobehttps://t.co/C8FHtEdYlf pic.twitter.com/FXwEOIg4Pf— Gabriele Pollara (@gpollara) August 22, 2022
Illustrations under a Creative Commons Attribution (CC BY 4.0) license
M-A | Incidence of cutaneous adverse events with Phosphoinositide 3-Kinase inhibitors as adjuvant therapy in patients with cancer.
14 Oct, 2022 | 14:01h | UTCIncidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer: A Systematic Review and Meta-analysis – JAMA Oncology (free for a limited period)


